BioStem Technologies, Inc. Common Stock (BSEM)

• Market cap: $64.5M
• 1 day: 5.26%
• 5 days: -2.31%
• 1 month: -7.09%
• 3 months: -7.09%
• 6 months: -7.09%
• Year to date: -7.09%
• 1 year: -7.09%
• 5 years: -7.09%
• 10 years: -7.09%
• Sector: Healthcare
• Industry: Biotechnology

About: BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. The company develops, manufactures, and sells tissue allografts for the wound care market with a focus on the treatment of diabetic, pressure, and venous ulcers. Utilizing its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. The company offers a comprehensive portfolio of high-quality brands that are trademarked and include VENDAJE AC, AmnioWrap2, and Others. The company generates key revenue from VENDAJE AC.

Employees: 2